Pancreatic Cancer Therapy

Watch a Surgical Webcast of a Whipple Procedure for Pancreatic Cancer with Dr. H. Richard Alexander.

The Pancreatic Cancer Therapy Service at the University of Maryland Greenebaum Cancer Center offers a highly specialized, multidisciplinary approach to the evaluation, diagnosis and treatment of patients with pancreatic cancer.

Our team consists of specialists who are nationally recognized experts in pancreas cancer and lead scientific efforts to develop new and more effective therapies that are offering hope to more and more patients each year. They meet weekly to review each patient's case and develop the best possible treatment plan.

Our Pancreatic Cancer Therapy Service provides:

  • the experience and knowledge of a complete team of GI cancer experts
  • access to the latest research and clinical trials in new drugs and combination therapies
  • cutting-edge technology, including Trilogy radiation therapy and state-of-the-art clinical and surgical facilities

Our patients receive the most comprehensive and effective treatment available anywhere.

Immediate Access to Cancer Surgeons

We place a high priority on providing patients with immediate access to our nationally renowned pancreas cancer specialists. To see a surgical oncology specialist for a consultation within two business days, please call our Patient Referral Office coordinator at 410-328-7904. (See also: Immediate Access to Cancer Experts.)

About Pancreatic Cancer

Each year, approximately 30,000 people are diagnosed with pancreatic cancer in the United States. Most of these are people over the age of 50 with no family history of the disease. Because its symptoms are not specific and no screening test is currently available, pancreatic cancer is often not diagnosed until it is at a fairly advanced stage. Aggressive treatment, with a combination of surgery to remove all or part of the pancreas followed by radiation and/or chemotherapy, offers the best outcome for patients.

Our Pancreatic Cancer Expertise

Average rating:
(based on 0 ratings)